Although clinical outcome assessments (COAs) are invaluable in clinical trial research, sensors and wearables are becoming increasingly popular for their ability to s to supplement patient self-reports with objective data. In this PharmVOICE article, Signant Health\u2019s Bill Byrom details why sponsor should consider using sensors and wearables and provides examples of how they can be applied. Capable of being worn passively by study participants, these devices also benefit study participants. Readers will discover how they make participation easier and safer through continuous, at-home monitoring. Click to read how Signant Health is harnessing the technology\u2019s potential to help top pharma companies improve their clinical trials.